A retrospective audit of an inpatient EHR export found pulmonary function report rows captured for only 10.8% of patients ...
Friendly Positive anti-U1-RNP antibodies alone do not establish mixed connective tissue disease. Diagnosis requires a ...
Everyday Health on MSN
4 signs your Duchenne muscular dystrophy treatment is working
It can be difficult to tell if medication is helping slow the progression of Duchenne muscular dystrophy. Get expert advice ...
Discover CHEST 2026 findings on CT phenotyping, TAPSE/sPAP risk scores, artesunate, telomere length and inhaled nintedanib in ...
A retrospective propensity-matched study of 120 hemodynamically stable patients found that chronic SGLT2 inhibitor use was ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...
MedPage Today on MSN
Novel breath test might distinguish fibrotic lung conditions
Sphingolipids in breath condensate had high predictive accuracy in distinguishing two cond ...
Researchers at the University of São Paulo (USP) in Brazil and their international collaborators have created a computational ...
Key points of this discussion]Asthma and COPD have overlapping symptoms and test findings. Distinguish between 'variable ...
Google-backed Nexus AI supports faster, offline TB screening, helping clinicians identify patients who need further testing.
Patients and researchers claim Cook failed to fully disclose the devices' risks and took advantage of a broken FDA process.
Distinct lipid signatures identified in blood plasma and exhaled breath can differentiate IPF from fibrotic hypersensitivity pneumonitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results